Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis

Abstract Background Type 2 diabetes mellitus (T2DM) is associated with myocardial fibrosis (MF), a major contributor to adverse cardiovascular outcomes. Cardiovascular magnetic resonance (CMR), specifically extracellular volume fraction (ECV) and native T1 mapping, offers a non-invasive approach to...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed Marey, Ali Alabdullah, Hossam Ghorab, Fatima Ali, Jawdat Abdulla, Akhil Narang, Muhammad Umair
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-025-04496-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572033160970240
author Ahmed Marey
Ali Alabdullah
Hossam Ghorab
Fatima Ali
Jawdat Abdulla
Akhil Narang
Muhammad Umair
author_facet Ahmed Marey
Ali Alabdullah
Hossam Ghorab
Fatima Ali
Jawdat Abdulla
Akhil Narang
Muhammad Umair
author_sort Ahmed Marey
collection DOAJ
description Abstract Background Type 2 diabetes mellitus (T2DM) is associated with myocardial fibrosis (MF), a major contributor to adverse cardiovascular outcomes. Cardiovascular magnetic resonance (CMR), specifically extracellular volume fraction (ECV) and native T1 mapping, offers a non-invasive approach to quantify MF. This study aims to evaluate the utility of ECV and native T1 mapping as biomarkers for cardiac fibrosis and to assess their relationship with diabetes severity, measured by hemoglobin A1C (HbA1C), in patients with T2DM. Methods A systematic review and meta-analysis were conducted following PRISMA guidelines. Comprehensive searches identified 19 eligible studies comprising 4,117 participants. Weighted mean differences (WMDs) were calculated for ECV and native T1 values between diabetic and non-diabetic groups. Meta-regression assessed the correlation between ECV and HbA1C. Sensitivity and subgroup analyses were performed to explore heterogeneity. Results Diabetic patients exhibited significantly higher ECV values than controls (WMD: 2.17; 95% CI: 1.32–3.02), consistent across subgroups excluding cardiac comorbidities (WMD: 2.02; 95% CI: 0.74–3.31). HbA1C levels were also significantly elevated in diabetics (WMD: 1.78; 95% CI: 1.37–2.19). However, no significant difference in native T1 values was observed (WMD: 13.40; 95% CI: -13.98–40.79). Meta-regression revealed no significant correlation between ECV and HbA1C, potentially due to limited data and high heterogeneity (I²: 93.37%). Conclusions ECV is a promising marker for quantifying MF in T2DM, demonstrating significant differences between diabetics and controls. The lack of correlation between ECV and HbA1C underscores the complexity of MF in diabetes and highlights the need for further research. Future studies with standardized protocols are essential to validate these findings and refine the use of CMR in diabetic cardiomyopathy.
format Article
id doaj-art-cea05af886ac4030bb4da34c8de69b2f
institution Kabale University
issn 1471-2261
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj-art-cea05af886ac4030bb4da34c8de69b2f2025-02-02T12:07:48ZengBMCBMC Cardiovascular Disorders1471-22612025-02-0125111110.1186/s12872-025-04496-zExtracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysisAhmed Marey0Ali Alabdullah1Hossam Ghorab2Fatima Ali3Jawdat Abdulla4Akhil Narang5Muhammad Umair6Alexandria University Faculty of MedicineDepartment of Surgery, Cleveland Clinic Abu DhabiAlexandria University Faculty of MedicineCMH Lahore Medical CollegeDepartment of Cardiology, Amager and Hvidovre HospitalDepartment of Cardiology, Northwestern UniversityRussell H. Morgan Department of Radiology and Radiological Sciences, The Johns Hopkins HospitalAbstract Background Type 2 diabetes mellitus (T2DM) is associated with myocardial fibrosis (MF), a major contributor to adverse cardiovascular outcomes. Cardiovascular magnetic resonance (CMR), specifically extracellular volume fraction (ECV) and native T1 mapping, offers a non-invasive approach to quantify MF. This study aims to evaluate the utility of ECV and native T1 mapping as biomarkers for cardiac fibrosis and to assess their relationship with diabetes severity, measured by hemoglobin A1C (HbA1C), in patients with T2DM. Methods A systematic review and meta-analysis were conducted following PRISMA guidelines. Comprehensive searches identified 19 eligible studies comprising 4,117 participants. Weighted mean differences (WMDs) were calculated for ECV and native T1 values between diabetic and non-diabetic groups. Meta-regression assessed the correlation between ECV and HbA1C. Sensitivity and subgroup analyses were performed to explore heterogeneity. Results Diabetic patients exhibited significantly higher ECV values than controls (WMD: 2.17; 95% CI: 1.32–3.02), consistent across subgroups excluding cardiac comorbidities (WMD: 2.02; 95% CI: 0.74–3.31). HbA1C levels were also significantly elevated in diabetics (WMD: 1.78; 95% CI: 1.37–2.19). However, no significant difference in native T1 values was observed (WMD: 13.40; 95% CI: -13.98–40.79). Meta-regression revealed no significant correlation between ECV and HbA1C, potentially due to limited data and high heterogeneity (I²: 93.37%). Conclusions ECV is a promising marker for quantifying MF in T2DM, demonstrating significant differences between diabetics and controls. The lack of correlation between ECV and HbA1C underscores the complexity of MF in diabetes and highlights the need for further research. Future studies with standardized protocols are essential to validate these findings and refine the use of CMR in diabetic cardiomyopathy.https://doi.org/10.1186/s12872-025-04496-zDiabetesMyocardial fibrosisExtracellular volume fractionT1 mappingCardiovascular magnetic resonanceDiabetic cardiomyopathy
spellingShingle Ahmed Marey
Ali Alabdullah
Hossam Ghorab
Fatima Ali
Jawdat Abdulla
Akhil Narang
Muhammad Umair
Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis
BMC Cardiovascular Disorders
Diabetes
Myocardial fibrosis
Extracellular volume fraction
T1 mapping
Cardiovascular magnetic resonance
Diabetic cardiomyopathy
title Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis
title_full Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis
title_fullStr Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis
title_full_unstemmed Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis
title_short Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis
title_sort extracellular volume fraction and native t1 mapping in diabetic cardiomyopathy a comprehensive meta analysis
topic Diabetes
Myocardial fibrosis
Extracellular volume fraction
T1 mapping
Cardiovascular magnetic resonance
Diabetic cardiomyopathy
url https://doi.org/10.1186/s12872-025-04496-z
work_keys_str_mv AT ahmedmarey extracellularvolumefractionandnativet1mappingindiabeticcardiomyopathyacomprehensivemetaanalysis
AT alialabdullah extracellularvolumefractionandnativet1mappingindiabeticcardiomyopathyacomprehensivemetaanalysis
AT hossamghorab extracellularvolumefractionandnativet1mappingindiabeticcardiomyopathyacomprehensivemetaanalysis
AT fatimaali extracellularvolumefractionandnativet1mappingindiabeticcardiomyopathyacomprehensivemetaanalysis
AT jawdatabdulla extracellularvolumefractionandnativet1mappingindiabeticcardiomyopathyacomprehensivemetaanalysis
AT akhilnarang extracellularvolumefractionandnativet1mappingindiabeticcardiomyopathyacomprehensivemetaanalysis
AT muhammadumair extracellularvolumefractionandnativet1mappingindiabeticcardiomyopathyacomprehensivemetaanalysis